Diversified Trust Co grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 52.0% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 4,680 shares of the medical equipment provider’s stock after buying an additional 1,601 shares during the quarter. Diversified Trust Co’s holdings in Intuitive Surgical were worth $1,903,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors also recently modified their holdings of ISRG. North Point Portfolio Managers Corp OH bought a new stake in shares of Intuitive Surgical in the third quarter valued at about $27,000. John Boyer Inc. acquired a new position in shares of Intuitive Surgical in the third quarter valued at about $27,000. Compass Wealth Management LLC acquired a new position in shares of Intuitive Surgical in the third quarter valued at about $29,000. Main Street Group LTD bought a new position in Intuitive Surgical during the first quarter worth about $30,000. Finally, Compass Financial Management LLC bought a new position in Intuitive Surgical during the second quarter worth about $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a report on Thursday. BNP Paribas Exane upgraded shares of Intuitive Surgical to an “outperform” rating in a research report on Tuesday, July 28th. Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 22nd. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Wednesday, October 21st. Finally, Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, October 31st. One research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $493.54.
View Our Latest Report on Intuitive Surgical
Insider Buying and Selling at Intuitive Surgical
In other Intuitive Surgical news, SVP Patricia L. Wadors sold 1,078 shares of the firm’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total value of $478,416.40. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $458.15, for a total value of $183,260.00. Following the completion of the transaction, the executive vice president owned 6,236 shares in the company, valued at approximately $2,857,023.40. The trade was a 6.03% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 39,379 shares of company stock valued at $17,739,043. 0.60% of the stock is currently owned by insiders.
Intuitive Surgical Price Performance
ISRG opened at $443.59 on Monday. The stock has a market capitalization of $153.77 billion, a price-to-earnings ratio of 53.64, a P/E/G ratio of 3.06 and a beta of 1.45. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88. The company has a 50-day simple moving average of $417.59 and a 200 day simple moving average of $429.98.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last released its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating the consensus estimate of $2.65 by $0.35. The firm had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The business’s quarterly revenue was up 21.7% compared to the same quarter last year. During the same period last year, the firm earned $2.40 EPS. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.
Intuitive Surgical Profile
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
